Lung health and germs in adults in Botswana
Part of Lungs & breathing clinical trials.
This study looks at how the lungs and tiny organisms in the body (microbiome) work together in adults living in Botswana. It may help doctors understand how to keep lungs healthier, especially for people with or without HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 35 years old or older
- You are at a clinic in Botswana
- You know your HIV status (positive or negative)
- You have not had a respiratory infection in the past 4 weeks
- You do not have active tuberculosis (TB)
- You have not had certain surgeries or a heart attack in the past 6 weeks
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system and natural germs in the lungs work in people who have recently been in close contact with someone with active tuberculosis (TB). It aims to better understand how the body responds to TB exposure.
This study looks at how immune cells in the lungs relate to the microbiome (the helpful microbes in the gut) in healthy adults. It may help scientists understand what affects lung health and immune balance.
This trial looks at how long-term health conditions like heart disease, diabetes, or high blood pressure might affect breathing problems. The goal is to better understand and help people with both issues.
This study looks at your lung health and overall wellbeing after finishing treatment for tuberculosis (TB). It aims to understand how TB affects breathing and quality of life, so doctors can better support recovery.
This study looks at bacteria and other substances in the body of people with COPD compared to healthy smokers, to find clues about how COPD affects health. It may help improve future treatments.
This study tests a program to improve lung health in people with breathing problems. It aims to help reduce symptoms and improve quality of life.
Hear when a new Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.